Linical at a Glance
We are a Global CRO Partner that Supports Drug Development, Leading to "Drugs of the Future".
Linical is a public, mid-sized Contract Research Organization headquartered in Japan with a significant presence across all major markets including North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, neurology & psychiatry, immunology & vaccine, and endocrinology & metabolic diseases. Rather than be all things to the market, this intentional design allows us to provide our clients the right size, right reach, and right team.
An Award-Winning CRO
Linical is an award winning CRO, and was been honored as a Vaccine Industry Excellence (ViE) Award nominee for Best CRO by industry leaders 11 consecutive years, after being evaluated against global CROs for quality of services, performance, client satisfaction, Sponsor relationships, and the overall value brought to study Sponsors. Additionally, in 2020, Linical was named a winner of the 2020 CRO Leadership Award for Overall Compatibility servicing a combination of both large and small pharma and biotech clientele. Presented by Life Science Leader and Clinical Leader, the Awards evaluated over 60 contract research organizations on more than 20 performance metrics in ISR’s annual CRO Quality Benchmarking survey. Linical was also recently honored with the 2020 and 2021 Global Excellence Award for Most Innovative CRO by Global Health & Pharma Magazine (GHP) and Most Outstanding Contract Research Service Provider 2021 for Full-Service Drug Development in Acquisition International Magazine's Global Excellence Awards.
Most recently, Linical was awarded the title of Best International CRO Service Provider 2023 by GHP Magazine, followed by Best Global CRO 2024 as part of Global Health and Pharma's annual Global Excellence Awards. Winners of the award are considered leading players in the pharmaceutical and life science industries, and are selected by the GHP Magazine committee, based on thorough analysis and an objective research process to award titles based purely on merit. The Global Excellence Awards celebrate those who have pushed the boundaries of possibility, redefined industry standards, and made significant strides in addressing the pressing challenges that impact the global landscape.
The Role of a CRO
CROs (Contract Research Organizations) carry out a part or all of the work involved in the clinical trials process of pharmaceutical product development on behalf of pharmaceutical and biotechnology companies. As specialists in new drug development, a CRO’s tasks can span many areas, including monitoring whether or not clinical trials are conducted in strict compliance with applicable laws and regulations, data management, and medical writing.
The Right-Choice CRO
Who We Serve
Phamaceutical Companies
Biotechnology Companies
Our Core Values
Kazuhiro Hatano
Linical is your CRO partner and gateway to the world, covering The Americas, Europe, and Asia Pacific.
Our global reach helps you streamline your regulatory process, enroll the right patients, and capture high-quality data with speed and precision.
Linical’s Data Highlights
Equity Ratio
Female managers in the Group
Learn More About Linical’s Sustainability Initiatives
Careers at Linical
Senior Project Manager
Successful clinical trials start with Linical.
Don’t let the complex clinical development journey hold you back. With Linical, you can overcome obstacles, save valuable time and money, and reach your goals.
01 Request a proposal
We start by listening to your needs and understanding your goals to ensure we’re the right CRO for you.
02 Get a plan for success
We propose solutions that proactively tackle obstacles, optimize your trial design, and position you for success every step of the way.
03 Execute with confidence
We’ll guide you through each phase of the process, offering personalized support and a full range of services to help you achieve a successful trial. We are not a “one size fits all” CRO.